A Boston Consulting Group study highlights how four companies, including a global biopharma leader, are harnessing Generative AI to drive large-scale cost transformations. Instead of incremental improvements, these organizations are redesigning entire functions, like R&D, procurement, and customer engagement, from the ground up using GenAI. This strategic shift enables faster innovation, improved decision-making, and significant cost savings.
The report underscores how enterprises that approach AI adoption holistically, focusing on culture, governance, and change management, are positioned to lead in the AI-driven economy. It signals a broader industry shift toward AI-native operating models that deliver both efficiency and differentiation.
